Status:
COMPLETED
FITBIT Study on Mobility and Readmissions After Radical Cystectomy
Lead Sponsor:
University of Pennsylvania
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a two-arm randomized, controlled trial during the postoperative period after major abdominal surgery for cancer, including for example radical cystectomy, nephrectomy, colectomy, comparing a c...
Detailed Description
We will conduct a two-arm randomized, controlled trial during the postoperative period after a radical cystectomy for bladder cancer, comparing a control group that uses a wearable device to track phy...
Eligibility Criteria
Inclusion
- Age 18 years or older
- diagnosis of cancer undergoing definitive surgical treatment
Exclusion
- Inability to provide consent
- does not have daily access to a smartphone compatible with the wearable device and not willing to use a device that the investigators can provide them
- any other medical conditions that would prohibit participation in a physical activity program
Key Trial Info
Start Date :
November 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2022
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04314778
Start Date
November 15 2019
End Date
August 15 2022
Last Update
December 24 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Abramson Cancer Center
Philadelphia, Pennsylvania, United States, 19104
2
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104